Second-line chemotherapy in human immunodeficiency virus-related non-Hodgkin's lymphoma: Evidence of activity of a combination of etoposide, mitoxantrone, and prednimustine in relapsed patients

Cancer

Volumn 77, Issue 10, 1996, Pages 2127-2131

  Tirelli, Umberto ^a   Errante, Domenico ^a   Spina, Michele ^a   Gastaldi, Roberta ^b   Nigra, Ezio ^c   Nosari, Anna Maria ^d   Magnani, Giacomo ^e   Vaccher, Emanuela ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c AMEDEO DI SAVOIA HOSPITAL   (Italy)

^d OSPEDALE NIGUARDA CA GRANDA   (Italy)

^e UNIVERSITY OF PARMA   (Italy)

Author keywords

HIV; Non Hodgkin's lymphoma; Second line treatment; Survival

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; MITOXANTRONE; PREDNIMUSTINE; PREDNISONE; TENIPOSIDE; VINCRISTINE;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MULTICENTER STUDY; NEUTROPENIA; NONHODGKIN LYMPHOMA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SEPSIS; THROMBOCYTOPENIA;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ETOPOSIDE; FEMALE; HIV INFECTIONS; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MITOXANTRONE; PREDNIMUSTINE; PROGNOSIS; PROSPECTIVE STUDIES; RECURRENCE; SURVIVAL RATE;

EID: 0029897838     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960515)77:10<2127::AID-CNCR25>3.0.CO;2-W     Document Type: Article

References (21)

1. Levine AM, Wernz JC, Kaplan L, Rodman N, Cohen P, Metroka K, et al. Low dose chemotherapy with central nervous system prophylaxis and zidovudine maintenance in AIDS-related lymphoma. JAMA 1991;266:84-8.
2. Gisselbrecht C, Oksenhendler E, Tirelli U, Lepage E, Gabarre J, Farcet JP, et al. Human immunodeficiency virus-related lymphoma treatment with intensive combination chemotherapy. Am J Med 1993;68:842-52.
3. Tirelli U, Errante D, Vaccher E, Serraino D, Carbone A. Long survival in patients with acquired immune deficiency syndrome-related primary central nervous system lymphoma. Cancer 1994;74:1990-1.
4. Lowenthal D, Straus D, Campbell SW, Gold JWM, Clarkson BD, Koziner B. AIDS-related lymphoid neoplasia. The Memorial Hospital experience. Cancer 1988;61:2325-37.
5. Knowles DM, Chamulak G, Subar M, Burke JS, Dugan M, Wernz J, et al. Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1988;108:744-53.
6. Bermudez M, Grant K, Rodvien R, Mendes F. Non-Hodgkin's lymphoma in a population with or at risk for acquired immunodeficiency syndrome: indications for intensive chemotherapy. Am J Med 1989;86:71-6.
7. Kaplan LD, Abrams DI, Feigal E, McGrath M, Khan J, Neville P, et al. AIDS-associated non-Hodgkin's lymphoma in San Francisco. JAMA 1989;261:719-24.
8. Tirelli U, Errante D, Oksenhendler E, Spina M, Vaccher E, Serraino D, et al. Prospective study with combined low-dose chemotherapy and zidovudine in 37 patients with poor-prognosis AIDS-related non-Hodgkin's lymphoma. Ann Oncol 1992;3:843-7.
9. Kahn J, Kaplan L, Northfelt D, Piro L, Beutler E, Carson D, et al. 2-Chlorodeoxyadenosine (2-CDA) for AIDS-associated non-Hodgkin's lymphoma (NHL). A phase 1 study. Proc Am Soc Clin Oncol [abstract 12]. 1991;10:34.
10. Tulpule A, Anderson LJJ, Levine AM, Espina B, Esplin J, Boswell W, et al. Anti-B4 (CD 19) monoclonal antibody, conjugated with ricin (B4-blocked ricin: B4BR) in refractory AIDS-lymphoma [abstract 10] Proc Am Soc Clin Oncol 1994;13:52.
11. Levine AM, Weiss G, Tulpule A, Kaplan L, Giles F, Luskey BD, et al. Multicenter phase II study of mitoguazone (MGBG) in relapsed or refractory AIDS-lymphoma [abstract 821]. Proc Am Soc Clin Oncol 1995;14:288.
12. Tirelli U, Zagonel V, Errante D, Serraino D, Talamini R, De Cicco M, et al. A prospective study of a new combination chemotherapy regimen in patients older than 70 years with unfavourable non-Hodgkin's lymphoma. J Clin Oncol 1992;10:228-36.
13. Santoro A, Viviani S, Valagussa P, Bonfante V, Bonadonna G. CCNU, etoposide, and prednimustine (CEP) in refractory Hodgkin's disease. Semin Oncol 1986;13(Suppl):23-6.
14. Landys K, Ridell B. Novantrone in combination with sterecyt in the treatment of unfavourable non-Hodgkin's lymphoma [abstract 9.43]. Proceedings of the Fifth NCI-EORTC Symposium on New Drugs in Cancer Therapy, Amsterdam, Holland, October 22-24, 1986:22.
15. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981;47:207-14.
16. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
17. Mantel M. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-70.
18. Sawka CA, Shepherd FA, Brandwein J, Burkes RL, Sutton DM, Warner E. Treatment of AIDS-related non-Hodgkin's lymphoma with a twelve week chemotherapy program. Leuk Lymphoma 1992;8:213-20.
19. Remick SC, McSharry JJ, Wolf BC, Blanchard CG, Eastman AY, Wagner H, et al. Novel oral combination chemotherapy in the treatment of intermediate-grade and high-grade AIDS-related Hodgkin's lymphoma. J Clin Oncol 1993;11: 1691-702.
20. Sparano JA, Wiernik PH, Strack M, Leaf A, Becker N, Valentine ES. Infusional cyclophosphamide, doxorubicin, and etoposide in human immunodeficiency virus- and human T-cell leukemia virus type I-related non-Hodgkin's lymphoma: a highly active regimen. Blood 1993;10:2810-5.
21. Demidem A, Broquet C, Mencia-Huerta JM, Salahuddin SZ, Lam T, Khan RS, et al. Sensitivity of drug resistant B cell lines from AIDS-related non-Hodgkin's lymphoma to newly synthesized podophyllotoxin derivatives and aza-alkyllysophospholipids: an enhanced sensitization by pretreatment with interferon gamma. Int J Oncol 1994;4:1203-9.